drugset / Trial / NCT04770701
Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes
NaSingle-groupOpen-labelTreatment
Summary
This is a plant-based medication used to increase the amount, protect, and reduce HIV's impact on T and B lymphocytes.
Timeline
- Start
- 2020-09-20
- Primary completion
- 2025-06-07
- Completion
- 2026-06-06
Outcome
Outcome not reported
Stopped (Enrollment): “The study was withdrawn before enrollment due to administrative and board approval constraints.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ahah | Unknown | — | — |